The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
高纯度、高活性、低内毒素、高批间一致性
-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
[93024ES]Recombinant Biotinylated Human LMP2 (HLA-A*11:01) Protein,His-Avi Tag
[93025ES]Recombinant Human LMP2 (HLA-A*11:01) Protein,His-Avi Tag
[93026ES]Recombinant Human LMP2 (HLA-A*11:01) Tetramer Protein,His-Avi Tag
[93027ES]Recombinant Human LMP2 (HLA-A*02:01) Complex Tetramer Protein,His-Avi Tag
[93028ES]Recombinant Biotinylated Human LMP2 (HLA-A*02:01) Complex Protein,His-Avi Tag
[93085ES]Recombinant Human&Mouse Chimeric LMP2 (HLA-A*02:01) Protein,His-Avi Tag
[93088ES]Recombinant Human&Mouse Chimeric LMP2 (HLA-A*02:01) Tetramer Protein,His-Avi Tag